The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Jazz Pharmaceuticals plc shares valued at $242,340 were sold by COZADD BRUCE C on Dec 02 ’24. At $121.17 per share, COZADD BRUCE C sold 2,000 shares. The insider’s holdings dropped to 427,025 shares worth approximately $51.99 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Carr Patricia sold 53 shares, netting a total of over 6,492 in proceeds. Following the sale of shares at $122.49 each, the insider now holds 6,596 shares.
Before that, COZADD BRUCE C had added 2,000 shares to its account. In a trade valued at $242,340, the Officer bought Jazz Pharmaceuticals plc shares for $121.17 each.
As published in a research note from Morgan Stanley on December 12, 2024, Jazz Pharmaceuticals plc [JAZZ] has been rated up from an Equal-weight to an Overweight and the price target has been revised to $175 from $140. Analysts at Goldman started covering the stock with ‘”a Buy”‘ outlook in a report released in early June. As of January 03, 2024, Robert W. Baird has initiated its “an Outperform” rating for JAZZ. Earlier on November 27, 2023, UBS downgraded its rating. Their new recommendation was “a Neutral” for JAZZ stock which previously was a “a Buy”.
Analyzing JAZZ Stock Performance
During the last five days, there has been a surge of approximately 0.84%. Over the course of the year, Jazz Pharmaceuticals plc shares have dropped approximately -1.02%. Shares of the company reached a 52-week high of $134.17 on 02/26/24 and a 52-week low of $99.06 on 07/10/24. A 50-day SMA is recorded $118.00, while a 200-day SMA reached $112.66. Nevertheless, trading volume fell to 1.15 million shares from 0.69 million shares the previous day.
Support And Resistance Levels for Jazz Pharmaceuticals plc (JAZZ)
According to the 24-hour chart, there is a support level at 120.35, which, if violated, would cause prices to drop to 118.96. In the upper region, resistance lies at 124.45. The next price resistance is at 127.16. RSI (Relative Strength Index) is 51.34 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.88, which suggests the price will decrease in the coming days. Percent R is at 57.61%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
